Real World Treatment Patterns In Chronic Lymphocytic Leukemia Patients In The United States - Rituximab, The Most Commonly Used Agent
May 1, 2014, 00:00
10.1016/j.jval.2014.03.1370
https://www.valueinhealthjournal.com/article/S1098-3015(14)01421-1/fulltext
Title :
Real World Treatment Patterns In Chronic Lymphocytic Leukemia Patients In The United States - Rituximab, The Most Commonly Used Agent
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)01421-1&doi=10.1016/j.jval.2014.03.1370
First page :
A235
Section Title :
Systemic Disorders/Conditions
Open access? :
No
Section Order :
842